Abstract
Molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing many kinds of alterations in the expression levels. To identify disease-altered genes better, we have developed an approach that searches for the genes which present a significant rank alteration in the rank of their expression profiles, by comparing an altered rank with another gene. The approach provides groups of genes and assigns a statistical measure of significance to each pair of genes selected. The method is evaluated using two experimental sets of microarrays. We investigated the possibility of inferring the rank reverse pairs and its possibility in diagnostic application when there is no prior knowledge of the genes belonging to disease, nor about the structure of gene regulatory network. We also show that rank reverse is a very powerful technique to diagnostic disease in the practical application and could be used prior to traditional biomarker discovery.
Keywords: Rank reverse, gene expression, diagnostic approach, chip, disease-altered gene
Current Bioinformatics
Title: Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression
Volume: 4 Issue: 3
Author(s): Wenguang Zhang, Jinquan Li, Rui Su and Wu Jianghong
Affiliation:
Keywords: Rank reverse, gene expression, diagnostic approach, chip, disease-altered gene
Abstract: Molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing many kinds of alterations in the expression levels. To identify disease-altered genes better, we have developed an approach that searches for the genes which present a significant rank alteration in the rank of their expression profiles, by comparing an altered rank with another gene. The approach provides groups of genes and assigns a statistical measure of significance to each pair of genes selected. The method is evaluated using two experimental sets of microarrays. We investigated the possibility of inferring the rank reverse pairs and its possibility in diagnostic application when there is no prior knowledge of the genes belonging to disease, nor about the structure of gene regulatory network. We also show that rank reverse is a very powerful technique to diagnostic disease in the practical application and could be used prior to traditional biomarker discovery.
Export Options
About this article
Cite this article as:
Zhang Wenguang, Li Jinquan, Su Rui and Jianghong Wu, Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression, Current Bioinformatics 2009; 4 (3) . https://dx.doi.org/10.2174/157489309789071039
DOI https://dx.doi.org/10.2174/157489309789071039 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Follow the ATP: Tumor Energy Production: A Perspective
Anti-Cancer Agents in Medicinal Chemistry Changing the Endocrine Dependence of Breast Cancer: Data and Hypotheses
Current Medicinal Chemistry Prognostic and Predictive Value of Epithelial to Mesenchymal Transitionassociated Markers in Oral Squamous Cell Carcinoma
Current Proteomics Inhibition of Hedgehog/Gli Signaling by Botanicals: A Review of Compounds with Potential Hedgehog Pathway Inhibitory Activities
Current Cancer Drug Targets A New Approach for β-cyclodextrin Conjugated Drug Delivery System in Cancer Therapy
Current Drug Delivery Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
Current Pharmaceutical Biotechnology The Role of Lifestyle Change in the Prevention and Treatment of NAFLD
Current Pharmaceutical Design Caveolin Involvement and Modulation in Breast Cancer
Mini-Reviews in Medicinal Chemistry Inhibitory Smad7: Emerging Roles in Health and Disease
Current Molecular Pharmacology Role of Carboplatin in the Treatment of Triple Negative Early- Stage Breast Cancer
Reviews on Recent Clinical Trials Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics
Current Drug Targets Drug Uptake Systems in Liver and Kidney
Current Drug Metabolism MicroRNA Dysregulation in Gastric Cancer
Current Pharmaceutical Design Amniotic Fluid Stem Cells: a Promising Therapeutic Resource for Cell-Based Regenerative Therapy
Current Pharmaceutical Design Relaxin-Like Peptides in Neoplastic Lesions
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Artificial Neural Networks for the Prediction of Response to Interferon Plus Ribavirin Treatment in Patients with Chronic Hepatitis C
Current Pharmaceutical Design The Influence of Host Factors on the Prognosis of Breast Cancer: Stroma and Immune Cell Components as Cancer Biomarkers
Current Cancer Drug Targets Chemotherapy Resistance in Breast Cancer
Current Cancer Therapy Reviews ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke
Current Pharmaceutical Design